# US 2004/0081996 A1 · Methods and products related to genotyping and DNA analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0081996 A1
- Document ID: US20040081996A1
- Status: Published application
- Kind: A1
- Application number: 10/676,154
- Filed: 2003-09-29
- Published: 2004-04-29
- Earliest claimed: 1998-09-25
- Assignees: Massachusetts Institute of Technology
- Inventors: John Landers; Barbara Jordan; David E. Housman; Alain Charest
- Web page: https://patentgrep.com/patent/US20040081996A1

## CPC

- C12Q 1/6837: using probe arrays or probe chips (C12Q1/6874 takes precedence)
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- C12Q 2600/172: Haplotypes
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

The invention encompasses methods and products related to genotyping. The method of genotyping of the invention is based on the use of single nucleotide polymorphisms (SNPs) to perform high throughput genome scans. The high throughput method can be performed by hybridizing SNP allele-specific oligonucleotides and a reduced complexity genome (RCG). The invention also relates to methods of preparing the SNP specific oligonucleotides and RCGs, methods of fingerprinting, determining allele frequency for a SNP, characterizing tumors, generating a genomic classification code for a genome, identifying previously unknown SNPs, and related compositions and kits.

## Claims

### Claim 1

A method for detecting the presence or absence of a single nucleotide polymorphism (SNP) allele in a genomic sample, the method comprising:
preparing a reduced complexity genoime (RCG) from the genomic sample, and
analyzing the RCG for the presence or absence of a SNP allele.

### Claim 2 (depends on 1)

The method of claim 1, wherein the analysis comprises hybridizing a SNP-ASO and the RCG, wherein the SNP-ASO is complementary to one allele of a SNP, whereby the allele of the SNP is present in the genomic sample if the SNP-ASO hybridizes with the RCG, and wherein the presence or absence of the SNP is used to characterize the genomic sample.

### Claim 3 (depends on 2)

The method of claim 2, wherein the RCG is immobilized on a surface.

### Claim 4 (depends on 2)

The method of claim 2, wherein the SNP-ASO is immobilized on a surface.

### Claim 5 (depends on 2)

The method of claim 2, wherein the SNP-ASO is individually hybridized with a plurality of RCGs.

### Claim 6 (depends on 1)

The method of claim 1, wherein the RCG is a PCR-derived RCG.

### Claim 7 (depends on 1)

The method of claim 1, wherein the RCG is a native RCG.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The method of any one of claims 1-7, wherein the method further comprises identifying a genotype of the genomic sample, whereby the genotype is identified by the presence or absence of the alleles of the SNP in the RCG.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7)

The method of any one of claims 1-7, wherein the genomic sample is obtained from a tumor.

### Claim 10 (depends on 9)

The method of claim 9, wherein a plurality of RCGs are prepared from genomic samples isolated from a plurality of subjects and the plurality of RCGs are analyzed for the presence of the SNP.

### Claim 11 (depends on 8)

The method of claim 8, wherein the presence or absence of the SNP allele is analyzed in a plurality of genomic samples selected randomly from a population, the method further comprising determining the allelic frequency of the SNP allele in the population by comparing the number of genomic samples in which the allele is detected and the number of genomic samples analyzed.

### Claim 12 (depends on 1)

The method of claim 1, wherein the RCG is prepared by performing degenerate oligonucleotide priming-polymerase chain reaction (DOP-PCR) using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes at least 7 TARGET nucleotide residues, wherein x is an integer from 0-9, and wherein each N is any nucleotide residue, and wherein the tag is a polynucleotide having from about 0 to about 20 nucleotides.

### Claim 13 (depends on 12)

The method of claim 12, wherein the TARGET nucleotide sequence includes at least 8 nucleotide residues.

### Claim 14 (depends on 6)

The method of claim 6, wherein the RCG is prepared by interspersed repeat sequence-polymerase chain reaction (IRS-PCR).

### Claim 15 (depends on 6)

The method of claim 6, wherein the RCG is prepared by arbitrarily primed-polymerase chain reaction (AP-PCR).

### Claim 16 (depends on 6)

The method of claim 6, wherein the RCG is prepared by adapter-polymerase chain reaction.

### Claim 17 (depends on 2)

The method of claim 2, wherein at least a fraction of the SNP-ASO is labeled.

### Claim 18 (depends on 17)

The method of claim 17, wherein an excess of a non-labeled SNP-ASO is added during the hybridization step, wherein the non-labeled oligonucleotide is complementary to a different allele of the same SNP than the labeled SNP-ASO.

### Claim 19 (depends on 17)

The method of claim 17, further comprising performing a parallel hybridization reaction wherein the RCG is hybridized with a labeled SNP-ASO, wherein the oligonucleotide is complementary to a different allele of the same SNP than the labeled SNP-ASO.

### Claim 20 (depends on 19)

The method of claim 19, wherein the two SNP-AGOs are distinguishably labeled.

### Claim 21 (depends on 17)

The method of claim 17, an excess of non-labeled SNP-ASO is present during the hybridization.

### Claim 22 (depends on 2)

The method of claim 2, wherein the SNP-ASO is composed of from about 10 to about 50 nucleotides residues.

### Claim 23 (depends on 22)

The method of claim 22, wherein the SNP-ASO is composed of from about 10 to about 25 nucleotides residues.

### Claim 24 (depends on 17)

The method of claim 17, wherein the label is a radioactive isotope.

### Claim 25 (depends on 24)

The method of claim 24, further comprising the step of exposing the RCG to a film to produce a signal on the film which corresponds to the radioactively labeled hybridization products if the SNP is present in the RCG.

### Claim 26 (depends on 17)

The method of claim 17, wherein the label is a fluorescent molecule.

### Claim 27 (depends on 26)

The method of claim 26, further comprising the step of exposing the RCG to an automated fluorescence reader to generate an output signal which corresponds to the fluorescently labeled hybridization products if the SNP is present in the RCG.

### Claim 28 (depends on 17)

The method of claim 17, wherein a plurality of SNP-ASOs are labeled with fluorescent molecules, each SNP-ASO being labeled with a spectrally distinct fluorescent molecule.

### Claim 29 (depends on 28)

The method of claim 28, wherein the number of SNP-ASOs having a spectrally distinct fluorescent molecule is at least two.

### Claim 30 (depends on 28)

The method of claim 28, wherein the number is selected from the group consisting of three, four and eight.

### Claim 31 (depends on 2)

The method of claim 2, wherein a plurality of RCGs are labeled with fluorescent molecules, each RCG being labeled with a spectrally distinct fluorescent molecule, and wherein all of the RCGs having a spectrally distinct fluorescent molecule.

### Claim 32 (depends on 1)

The method of claim 1, wherein the RCG is prepared by performing degenerate oligonucleotide priming-polymerase chain reaction using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes fewer than 7 TARGET nucleotide residues wherein x is an integer from 0 to 9, wherein each N is any nucleotide residues, and wherein the tag is a polynucleotide having from about 0-20 nucleotides.

### Claim 33 (depends on 32)

The method of claim 32 wherein the TARGET nucleotide sequence includes at least 5 nucleotide residues.

### Claim 34 (depends on 32)

The method of claim 32 wherein the TARGET nucleotide sequence includes at least 6 nucleotide residues.

### Claim 35 (depends on 2)

The method of claim 2, wherein the RCG is labeled.

### Claim 36 (depends on 4)

The method of claim 4, wherein a plurality of different SNP-ASOs are attached to the surface.

### Claim 37 (depends on 1)

The method of claim 1, wherein the RCG is prepared by performing multiple primed DOP-PCR.

### Claim 38 (depends on 2)

The method of claim 2, wherein the genomic sample is characterized by generating a genomic pattern based on the presence or absence of the allele of the SNP in the genomic sample.

### Claim 39 (depends on 38)

The method of claim 38, wherein the genomic pattern is a genomic classification code.

### Claim 40

A method for characterizing a tumor, the method comprising:
isolating genomic DNA from tumor samples obtained from a plurality of subjects,
preparing a RCGs from each genomic DNA,
performing a hybridization reaction with a SNP-ASO and the plurality of RCGs, wherein the SNP-ASO is complementary to one allele of a SNP, and
characterizing the tumor based on whether the SNP-ASO hybridizes with at least some of the RCGs, whereby if the SNP oligonucleotide hybridizes with at least some of the RCGs, then the allele of the SNP is present in the genomic DNA of the tumor.

### Claim 41 (depends on 40)

The method of claim 40, wherein the hybridization reaction is performed with a plurality of SNP-ASOs immobilized on a surface, and wherein the hybridization is performed on the plurality of RCGS, each RCG being analyzed separately.

### Claim 42 (depends on 40)

The method of claim 40, wherein the RCGs are prepared by performing POP-PCR using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes at least 7 TARGET nucleotide residues and wherein x1 is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues.

### Claim 43 (depends on 42)

The method of claim 42, wherein the TARGET nucleotide sequence includes at least 8 nucleotide residues.

### Claim 44 (depends on 40)

The method of claim 40, wherein the RCGs are PCR-generated RCGs.

### Claim 45 (depends on 40)

The method of claim 40, wherein the RCGs are native RCGs.

### Claim 46 (depends on 40)

The method of claim 40, wherein the RCG is prepared by performing DOP-PCR using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes has fewer than 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues

### Claim 47

A method for generating a genomic pattern for an individual genome, the method comprising:
preparing a RCG from the individual genome,
analyzing the RCG for the presence or absence of at least one SNP allele, and
generating a genomic pattern for the individual genome based on the presence or absence of SNP alleles.

### Claim 48 (depends on 47)

The method of claim 47, wherein analyzing the RCG involves a hybridizing the RCG with a panel of SNP-ASOs, each of which is complementary to one allele of a SNP, and identifying the genomic pattern by determining the ability of the RCG to hybridize with each SNP-ASO.

### Claim 49 (depends on 47)

The method of claim 47, wherein the genomic pattern is a genomic classification code which is generated from the pattern of SNP alleles for each RCG.

### Claim 50 (depends on 49)

The method of claim 49, wherein the genomic classification code is also generated using the allelic frequency of the SNPs.

### Claim 51 (depends on 47)

The method of claim 47, wherein the genomic pattern is a visual pattern.

### Claim 52 (depends on 47)

The method of claim 47, wherein the genomic pattern is a digital pattern.

### Claim 53 (depends on 48)

The method of claim 48, wherein the SNP-ASOs are immobilized on a surface.

### Claim 54 (depends on 47)

The method of claim 47, further comprising performing a parallel reaction wherein the hybridization reaction is performed using a panel of labeled complementary SNP-ASOs.

### Claim 55 (depends on 54)

The method of claim 54, wherein the RCG is immobilized on a surface and wherein each SNP-ASO of the panel is hybridized with a separate surface.

### Claim 56 (depends on 54)

The method of claim 54, wherein the RCGs is immobilized on a surface and wherein a plurality of SNP-ASOs of the panel are hybridized with a single surface, each SNP-ASO being labeled with a spectrally distinct fluorescent molecule.

### Claim 57 (depends on 47)

The method of claim 47, wherein the RCGs is prepared by performing DOP-PCR using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes at least 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues.

### Claim 58 (depends on 47)

The method of claim 47, wherein the RCG is a PCR-generated RCG.

### Claim 59 (depends on 47)

The method of claim 47, wherein the RCG is a native RCG.

### Claim 60 (depends on 47)

The method of claim 47, wherein the RCG is prepared by performing DOP-PCR using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes less than 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues

### Claim 61

A method for generating a genomic classification code for a genome, the method comprising:
preparing a RCG from the genome,
analyzing the RCG for the presence or absence of SNP alleles of known allelic frequency, and
identifying a genomic pattern of SNP alleles for the RCG by determining the presence or absence therein of SNP alleles, and
generating a genomic classification code for the RCG based on the presence or absence and the allelic frequency of the SNP alleles.

### Claim 62 (depends on 61)

The method of claim 61, wherein the RCG is hybridized reaction with a panel of SNP-ASOs of known allelic frequency, each of which is complementary to one allele of a SNP, and identifying the genomic pattern based on whether each SNP-ASO hybridizes with the RCG.

### Claim 63 (depends on 62)

The method of claim 62, wherein the SNP-ASOs are immobilized on a surface.

### Claim 64 (depends on 62)

The method of claim 62, wherein the RCG is immobilized on a surface.

### Claim 65 (depends on 61)

The method of claim 61, wherein the RCG is prepared by performing POP-PCR using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes at least 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues.

### Claim 66 (depends on 61)

The method of claim 61, wherein the RCG is a PCR-generated RCG.

### Claim 67 (depends on 61)

The method of claim 61, wherein the RCG is a native RCG.

### Claim 68 (depends on 61)

The method of claim 61, wherein the RCG is prepared by performing DOP-PCR using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes less than 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues.

### Claim 69

A composition, comprising:
a plurality of RCGs immobilized in an ordered array on a surface.

### Claim 70 (depends on 69, 125)

The composition of claim 69, wherein the RCGs prepared by the method of claim 125.

### Claim 71 (depends on 69)

The composition of claim 69, wherein the RCGs are PCR-generated RCGs.

### Claim 72 (depends on 69)

The composition of claim 69, wherein the RCGs are native RCGs.

### Claim 73

A kit, comprising:
a container housing a set of polymerase chain reaction primers for reducing the complexity of a genome, and
a container housing a set of SNP-ASOs, wherein the SNPs are present with a frequency of at least 50% in a RCG made using the set of primers.

### Claim 74 (depends on 73)

The kit of claim 73, wherein the SNP-ASOs are attached to a surface.

### Claim 75 (depends on 73, 74)

The kit of any one of claims 73 or 74, wherein the set of polymerase chain reaction primers are primers for DOP-PCR.

### Claim 76 (depends on 75)

The kit of claim 75, wherein the degenerate oligonucleotide primer has a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes at least 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues.

### Claim 77 (depends on 76)

The kit of claim 76, wherein the TARGET nucleotide sequence includes at least 8 nucleotide residues.

### Claim 78 (depends on 76)

The kit of claim 76, wherein the TARGET nucleotide sequence includes at least 9 nucleotide residues.

### Claim 79 (depends on 76)

The kit of claim 76, wherein the TARGET nucleotide sequence includes at least 10 nucleotide residues.

### Claim 80 (depends on 76)

The kit of claim 76, wherein the TARGET nucleotide sequence includes at least 11 nucleotide residues.

### Claim 81 (depends on 76)

The kit of claim 76, wherein the TARGET nucleotide sequence includes 12 nucleotide residues.

### Claim 82 (depends on 73, 74)

The kit of any one of claims 73 or 74, wherein the set of polymerase chain reaction primers are primers for ISR-PCR.

### Claim 83 (depends on 73, 74)

The kit of any one of claims 73 or 74, wherein the set of polymerase chain reaction primers are primers for AP-PCR.

### Claim 84 (depends on 73, 74)

The kit of any one of claims 73 or 74, wherein the set of polymerase chain reaction primers are primers for adapter-polymerase chain reaction.

### Claim 85 (depends on 73, 74)

The kit of any one of claims 73 or 74, wherein the SNP-ASOs are composed from 10 and 50 nucleotide residues.

### Claim 86 (depends on 73, 74)

The kit of any one of claims 73 or 74, wherein the SNP-ASOs are composed of from 10 and 25 nucleotide residues.

### Claim 87 (depends on 73, 74)

The kit of any one of claims 73 or 74, wherein the SNP-ASOs are labeled with a fluorescent molecule.

### Claim 88 (depends on 75)

The kit of claim 75, wherein the degenerate oligonucleotide primer has a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes fewer than 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues.

### Claim 89 (depends on 73)

The kit of claim 73, wherein the set of polymerase chain reaction primers are primers for multiple-primed DOP-PCR.

### Claim 90

A composition comprising:
a plurality of RCGs immobilized on a surface, wherein the RCGs are composed of a plurality of DNA fragments, each DNA fragment comprising a (N)x-TARGET nucleotide portion, wherein the nucleotide sequence of TARGET is identical in each of the DNA fragments, wherein TARGET is a polynucleotide consisting of at least 7 nucleotide residues, wherein x is an integer from 0 to 9, and wherein N is any nucleotide residue.

### Claim 91 (depends on 90)

The composition of claim 90, wherein the TARGET nucleotide sequence includes 8 nucleotide residues.

### Claim 92 (depends on 90)

The composition of claim 90, wherein the TARGET nucleotide sequence includes 9 nucleotide residues.

### Claim 93 (depends on 90)

The composition of claim 90, wherein the TARGET nucleotide sequence includes 10 nucleotide residues.

### Claim 94 (depends on 90)

The composition of claim 90, wherein the TARGET nucleotide sequence includes 11 nucleotide residues.

### Claim 95 (depends on 90)

The composition of claim 90, wherein the TARGET nucleotide sequence includes 12 nucleotide residues.

### Claim 96 (depends on 90, 91, 92, 93, 94, 95)

The composition of any one of claims 90-95, wherein x is from 3 to 9.

### Claim 97

The composition of any one of 90-95, wherein x is 6.

### Claim 98

The composition of any one of 90-95, wherein x is 7.

### Claim 99

The composition of any one of 90-95, wherein x is 8.

### Claim 100

The composition of any one of 90-95, wherein x is 9.

### Claim 101

A method for identifying a SNP, the method comprising:
preparing a set of primers from a RCG, wherein the RCG comprises a set of polymerase chain reaction (PCR) products,
performing PCR using the set of primers on at least one of isolated genome to produce a set of DNA products, and
identifying a SNP on the set of DNA products.

### Claim 102 (depends on 101)

The method of claim 101, wherein the plurality of isolated genomes is a pool of genomes.

### Claim 103 (depends on 101)

The method of claim 101, wherein the isolated genomes are RCGs.

### Claim 104 (depends on 103)

The method of claim 103, wherein the RCG is prepared by DOP-PCR.

### Claim 105 (depends on 101)

The method of claim 101, wherein the step of preparing the set of primers is performed by at least the following steps:
preparing a RCG and separating the set of PCR products in the RCG into individual PCR products,
determining the sequence of each end of at least one of the PCR products, and
generating primers for use in the subsequent PCR step based on the sequence of the ends of the inserts.

### Claim 106 (depends on 105)

The method of claim 105, wherein the set of PCR products are separated by gel electrophoresis.

### Claim 107 (depends on 106)

The method of claim 106, further comprising the step of preparing libraries from segments of the gel containing several PCR products and isolating clones from the library, each clone including a PCR product containing plasmid from the library.

### Claim 108 (depends on 105)

The method of claim 105, wherein the set of PCR products are separated by high pressure liquid chromatography.

### Claim 109 (depends on 105)

The method of claim 105, wherein the set of PCR products are separated by column chromatography.

### Claim 110 (depends on 101)

The method of claim 101, wherein the RCG is prepared by performing DOP-PCR using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes at least 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues.

### Claim 111 (depends on 110)

The method of claim 110, wherein the TARGET nucleotide sequence includes 8 nucleotide residues.

### Claim 112 (depends on 110)

The method of claim 110, wherein the TARGET nucleotide sequence includes 9 nucleotide residues.

### Claim 113 (depends on 110)

The method of claim 110, wherein the TARGET nucleotide sequence includes 10 nucleotide residues.

### Claim 114 (depends on 110)

The method of claim 110, wherein the TARGET nucleotide sequence includes 11 nucleotide residues.

### Claim 115 (depends on 110)

The method of claim 110, wherein the TARGET nucleotide sequence includes 12 nucleotide residues.

### Claim 116 (depends on 101)

The method of claim 101, wherein the RCG is prepared by IRS-PCR.

### Claim 117 (depends on 101)

The method of claim 101, wherein the RCG is prepared by AP-PCR.

### Claim 118 (depends on 101)

The method of claim 101, wherein the RCG is prepared by adapter-polymerase chain reaction.

### Claim 119 (depends on 101)

The method of claim 101, wherein the RCG is prepared by performing DOP-PCR using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes less than 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues.

### Claim 120 (depends on 101)

The method of claim 101, wherein x is greater than one.

### Claim 121 (depends on 101)

The method of claim 101, wherein the first and second steps of PCR products are generated using the same primers.

### Claim 122 (depends on 101)

A composition comprising:
a panel of SNP-ASOs immobilized on a surface, wherein the SNP-ASOs are prepared by the method of claim 101.

### Claim 123 (depends on 122)

The composition of claim 122, wherein each SNP-ASO is immobilized in a discrete area of the surface.

### Claim 124 (depends on 122)

The composition of claim 122, further comprising a panel of complementary SNP-ASOs immobilized on discrete areas of the surface.

### Claim 125

A method for obtaining a RCG using DOP-PCR, the method comprising:
performing DOP-PCR using a degenerate oligonucleotide primer having a tag-(N)x-TARGET nucleotide sequence, wherein the TARGET nucleotide sequence includes at least 7 TARGET nucleotide residues and wherein x is an integer from 0 to 9, wherein each N is any nucleotide residue, and wherein each tag is a polynucleotide having from 0 to about 20 nucleotide residues.

### Claim 126 (depends on 125)

The method of claim 125, wherein the TARGET nucleotide sequence includes 8 nucleotide residues.

### Claim 127 (depends on 125)

The method of claim 125, wherein the TARGET nucleotide sequence includes 9 nucleotide residues.

### Claim 128 (depends on 125)

The method of claim 125, wherein the TARGET nucleotide sequence includes 10 nucleotide residues.

### Claim 129 (depends on 125)

The method of claim 125, wherein the TARGET nucleotide sequence includes 11 nucleotide residues.

### Claim 130 (depends on 125)

The method of claim 125, wherein the TARGET nucleotide sequence includes 12 nucleotide residues.

### Claim 131

The method of any one of 125-130, wherein x is from 3 to 9.

### Claim 132

The method of any one of 125-130, wherein x is 6.

### Claim 133

The method of any one of 125-130, wherein x is 7.

### Claim 134

The method of any one of 125-130, wherein x is 8.

### Claim 135

The method of any one of 125-130, wherein x is 9.

### Claim 136 (depends on 125)

The method of claim 125, wherein the tag includes 6 nucleotide residues.

### Claim 137

The method of any one of 125-136, further comprising using the RCG in a genotyping procedure.

### Claim 138

The method of any one of 125-136, further comprising analyzing the RCG to detect a polymorphism.

### Claim 139 (depends on 138)

The method of claim 138 wherein the RCG is analyzed using mass spectroscopy.

### Claim 140 (depends on 1)

A method for assessing whether a subject is at risk for developing a disease, the method comprising:
preparing a RCG from a genomic sample obtained from the subject and characterizing the sample by the method of claim 1, whether one sample based on the presence or absence in the sample of a plurality of SNP alleles that occur in at least 10% of genomes obtained from individuals afflicted with the disease occur in the reduced subject complexity genome.

### Claim 141

A method for identifying a set of SNP alleles associated with a disease, the method comprising:
preparing individual RCGs obtained from subjects afflicted with a disease using the same set of primers to prepare each RCG, and
comparing individual genetic loci in the RCGs with the same individual genetic loci in normal subjects to identify SNP associated with the disease.

### Claim 142

A digital information product for representing genomic information, the product comprising:
a computer-readable medium having computer-readable signals stored thereon, wherein the signals define a data structure, the data structure including one or more data components,
wherein each data component includes:
a first data element defining a genomic classification code that identifies a corresponding genome, and wherein each genomic classification code classifies the corresponding genome based one or more single nucleotide polymorphisms of the corresponding genome.

### Claim 143 (depends on 142)

The difital information proiduc of claim 142, wherein the genomic classification code is a unique identifier of the corresponding genome.

### Claim 144 (depends on 142)

The digital information product of claim 142, wherein the genomic classification code is based on a pattern of the single nucleotide polymorphisms of the corresponding genome, the pattern indicating the presence or absence of each single nucleotide polymorphism.

### Claim 145 (depends on 142)

The digital information product of claim 142, wherein each data component also includes:
one or more data elements, each data element defining an attribute of the corresponding genome.

### Claim 146

A process for making a digital information product comprising computer data signals defining a genomic classification code for a genome, the process comprising:
preparing a reduced complexity genome,
performing a hybridization reaction with the reduced complexity genome and at least one surface having a panel of single nucleotide polymorphism oligonucleotides immobilized thereon,
identifying a genomic pattern of single nucleotide poymorphisms for the reduced complexity genome by determining the presence therein of single nucleotide polymorphisms based on whether each single nucleotide polymorphism oligonucleotide hybridizes to the reduced complexity genome,
generating a genomic classification code for the reduced complexity genome based on the genomic pattern of the single nucleotide polymorphisms, and
encoding the genomic classification code as one or more computer data signals on a computer-readable medium.

### Claim 147

A process for making a digital information product comprising computer data signals defining a genomic classification code for a genome, the process comprising:
preparing a reduced complexity genome,
performing a hybridization reaction with a panel of single nucleotide polymorphism oligonucleotides of known allelic frequency and a surface having the reduced complexity genome immobilized thereon,
identifying a genomic pattern of single nucleotide polymorphisms for the reduced complexity genome by determining the presence therein of single nucleotide polymorphisms based on whether each single nucleotide polymorphism oligonucleotide hybridizes to the reduced complexity genome,
generating a genomic classification code for the reduced complexity genome based on the pattern and the allelic frequency of the single nucleotide polymorphisms, and
encoding the genomic classification code as one or more computer data signals on a computer-readable medium.

### Claim 148

A method for performing linkage analysis, comprising:
preparing individual RCGs obtained from members of one or more families,
determining the presence or absence of SNP alleles in the RCGs, and
comparing the RCGs of the family members by comparing the presence or absence of the SNP alleles in the RCGs of the family members.
